Essure Litigation – Status Update

On July 20, 2018, Bayer issued a press release announcing that, as of December 2018, Essure would no longer be sold in the United States. To many, this decision seems long overdue, particularly in light of the fact that, since September of 2017, Bayer had removed Essure from every other market outside of the U.S. Of course, this decision does not come without controversy. Despite the number of safety concerns reported to the FDA almost…

Read More »

Market Removal of Essure

Bayer Pharmaceuticals announced on July 20, 2018, that distribution of Essure, the controversial and permanent birth control device, will wind down by the end of this year. The voluntary removal was described as numbers driven due to a sharp decline in sales. While discontinuing Essure has been communicated as a business decision, the years of corporate greed and debate surrounding the device tell a different story. Bayer AG purchased the maker of Essure in 2013,…

Read More »

Black Box Warning Added to Essure

One of the key responsibilities of the Food and Drug Administration (FDA) is to protect the public health by ensuring the safety and efficacy of pharmaceuticals and medical devices.  While it is the responsibility of a manufacturer to perform safety testing, the FDA approves a drug or device based on the safety studies conducted and reported by the manufacturer. In instances where a safety issue does not become apparent until after a drug or device…

Read More »

Getting Essure Removed: What You Need to Know

Since the permanent birth control device Essure went on the market in 2002, 26,000 complaints and 16,000 lawsuits have been filed against Bayer, the manufacturer of the device. As a result of the chronic and debilitating side effects (nickel poisoning, abnormal/heavy menstrual bleeding, autoimmune disorders, severe abdominal/pelvic pain, etc.) caused by Essure, many women have had to have the device removed. However, prior to implantation, women were not only ill-informed about the side effects of…

Read More »

Essure: The Controversy Behind this Female Sterilization Device

In 2002, Bayer released a permanent contraception device called Essure. The device presented women with the option of having two “soft, flexible inserts” implanted through the vagina and cervix into the fallopian tubes in a “gentle, non-surgical” procedure. Bayer promoted this approach as a drastically simpler alternative to the incision and anesthesia necessary for a tubal ligation surgery. The Essure coil-like inserts were designed to generate scar tissue to block the fallopian tubes, without releasing…

Read More »